Amir Salam in League City, Texas

Home Texas League City

Amir Salam has Medical Oncology as his primary medical specialty. Their primary office is: 2555 Gulf Fwy S in League City, Texas. There is an additional office location, for a total of two, for Amir Salam that can be viewed further down.

They're a part of the: Oncology Consultants, P. A.. medical group which has around 38 members. You can call their office at 713-800-0660 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Texas A & M University System, Hsc, College Of Medicine and graduated in 2013 (around 11 years of experience). They are listed as doing telehealth appointments.

Amir Q Salam Office Phone and Directions

Amir Salam
Oncology Consultants, P. A..
2555 Gulf Fwy S
League City, Texas 77573
713-800-0660

Patient Ratings
Please rate your experience with Amir Salam below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 713-800-0660

Enter a starting address:

Healthcare Info for Amir Salam

Medical School: Texas A & M University System, Hsc, College Of Medicine
Graduation Year: 2013
The Primary Medical Specialty for Amir Salam is listed as: Medical Oncology
Approximate Years of Experience: 11
PAC (PECOS ID)#: 1850611625
NPI #: 1346569316
NPI Created On: 05/28/2010
NPI Last Updated Listed as: 08/20/2020
Primary Taxonomy Code: 207R00000X
License Number:
BP10037100
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Community Health Choice
Molina Marketplace
Celtic Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Arabic, Urdu, Hindi.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140841

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140839

Being Disputed:: No

Product Related: No

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140843

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140845

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140847

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140851

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140853

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788140855

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007119

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Additional Office Locations

1. Oncology Consultants, P. A..
1920 Country Place Pkwy
Pearland, TX 77584
Suite 370
Group Members: 38

Phone: 713-800-0660

Enter a starting address:

Medical Oncology Professionals in League City

1.
Christopher Logothetis

2240 Gulf Fwy S
League-city, TX
Physicians Referral Service

2.
Christopher Logothetis

2280 Gulf Fwy S
League-city, TX
Physicians Referral Service

Providers in Oncology Consultants, P. A..

1.Mona Alattar

925 Gessner Rd
Houston Tx 77024-2645
Oncology Consultants, P. A..
Hematology/oncology

2.Munaf Alkadimi

2130 W Holcombe Blvd
Houston Tx 77030-3306
Oncology Consultants, P. A..
Medical Oncology

3.Munaf Alkadimi

1920 Country Place Pkwy
Pearland Tx 77584-1962
Oncology Consultants, P. A..
Medical Oncology

4.Ricardo Alvarez

925 Gessner Rd
Houston Tx 77024-2645
Oncology Consultants, P. A..
Internal Medicine

5.Ricardo Alvarez

23960 Katy Fwy
Katy Tx 77494-0886
Oncology Consultants, P. A..
Internal Medicine

6.Meaghan Brown

925 Gessner Rd
Houston Tx 77024-2645
Oncology Consultants, P. A..
Nurse Practitioner

View all 38 members of Oncology Consultants, P. A.. medical group